Characterization of gyrA mutations associated with fluoroquinolone resistance in Campylobacter coli by DNA sequence analysis and MAMA PCR

被引:80
作者
Zirnstein, G
Helsel, L
Li, Y
Swaminathan, B
Besser, J
机构
[1] Ctr Dis Control & Prevent, Natl Ctr Infect Dis, US PHS, US Dept HHS, Atlanta, GA 30333 USA
[2] Minnesota Dept Hlth, Minneapolis, MN USA
关键词
Campylobacter coli; ciprofloxacin resistance; mismatch polymerase chain reaction; gyrA mutation;
D O I
10.1016/S0378-1097(00)00306-2
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Increasing numbers of fluoroquinolone-resistant Campylobacter ter coli isolates received at the Minnesota State Public Health Laboratory and at the Centers for Disease Control and Prevention have been a cause for concern. The gyrA quinolone resistance-determining regions of several fluoroquinolone-resistant isolates were sequenced to examine the mechanism of resistance. Ciprofloxacin-resistant C. coli isolates examined by DNA sequencing had a Thr-86 to Ile (ACT --> ATT) gyrA mutation, leading to resistance to fluoroquinolone antibiotics. A mismatch amplification mutation assay polymerase chain reaction protocol was developed to detect this gyrA mutation. (C) 2000 Federation of European Microbiological Societies. Published by Elsevier Science B.V. All rights reserved.
引用
收藏
页码:1 / 7
页数:7
相关论文
共 28 条
[11]   Antibiotic susceptibility of campylobacter isolates from sewage and poultry abattoir drain water [J].
Koenraad, PMFJ ;
JacobsReitsma, WF ;
VanderLaan, T ;
Beumer, RR ;
Rombouts, FM .
EPIDEMIOLOGY AND INFECTION, 1995, 115 (03) :475-483
[12]   USE OF AZITHROMYCIN FOR THE TREATMENT OF CAMPYLOBACTER ENTERITIS IN TRAVELERS TO THAILAND, AN AREA WHERE CIPROFLOXACIN RESISTANCE IS PREVALENT [J].
KUSCHNER, RA ;
TROFA, AF ;
THOMAS, RJ ;
HOGE, CW ;
PITARANGSI, C ;
AMATO, S ;
OLAFSON, RP ;
ECHEVERRIA, P ;
SADOFF, JC ;
TAYLOR, DN .
CLINICAL INFECTIOUS DISEASES, 1995, 21 (03) :536-541
[13]   Rapid identification by PCR of the genus Campylobacter and of five Campylobacter species enteropathogenic for man and animals [J].
Linton, D ;
Owen, RJ ;
Stanley, J .
RESEARCH IN MICROBIOLOGY, 1996, 147 (09) :707-718
[14]   THE MOLECULAR-BASIS OF QUINOLONE ACTION [J].
MAXWELL, A .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1992, 30 (04) :409-414
[15]   CAMPYLOBACTER INFECTIONS [J].
NACHAMKIN, I .
CURRENT OPINION IN INFECTIOUS DISEASES, 1993, 6 (01) :72-76
[16]  
*NAT COMM CLIN LAB, 1997, M7A4 NAT COMM CLIN L
[17]  
*NAT SURV PROGR AN, 1996, MORBIDITY MORTALITY, V45, P110
[18]  
National Committee for Clinical Laboratory Standards, 1998, M100S8 NAT COMM CLIN
[19]   Quinolone resistance and Campylobacter spp. [J].
Piddock, LJV .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1995, 36 (06) :891-898
[20]   HIGH-LEVEL QUINOLONE RESISTANCE IN CLINICAL ISOLATES OF CAMPYLOBACTER-JEJUNI [J].
SEGRETI, J ;
GOOTZ, TD ;
GOODMAN, LJ ;
PARKHURST, GW ;
QUINN, JP ;
MARTIN, BA ;
TRENHOLME, GM .
JOURNAL OF INFECTIOUS DISEASES, 1992, 165 (04) :667-670